Fertility Services Market by Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others) and Service (Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor): Global Opportunity Analysis and Industry Forecast, 2021–2027

ID: VPR/HC/192 Publishing Year: January 2021 Pages: 108 Format:   


The Global Fertility Services Market generated $XX million in 2019 and is projected to reach $XX million by 2027, growing at a CAGR of XX% from 2021 to 2027.Fertility services are the services which assist couples or single parents who wants to become parents but are unable to achieve via natural process. Fertility services apply number of tests and advance medical treatments for achieve conceptions and pregnancies. The staff in fertility clinics are well trained and equipped with advanced treatments which includes reproductive endocrinologists, embryologistssonographers.

The growth in middle age women who are willing to become mothers are driver the market. The average of the first-time pregnant women is seen in 20’s or late 30’s ,technological advancements in fertility treatment and increasing prevalence of obesity are drivers for the growth of market. Moreover ,consumption of cigarettes and alcohol which results in poor fertility is anticipated to drive the market growth. Fertility services comprising the usage of novel technologies are associated with higher success rates, for instance, the use of incubators, imaging systems, and software to check the growth development of embryos. However, cost of treatment may hamper the growth of the Fertility Service Market.

Segmentation of Fertility Service Market:

The Global Fertility Service Market is segmented into by procedure ,by service and region. On the basis of procedure it is further divided into IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others. On the basis of service it is divided into Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor. Region wise it is observed across north America ,Europe, Asia-pacific and LAMEA.

By Procedure Insight:

By procedure ,IVF with ICSI is prominent to growth throughout the forecast period. This segment is expected to exhibit a prominent growth rate, owing to some key factors such higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others. Moreover, rapid increase in infertility rate is one of the major factors that drive the Fertility Services Market.

By Service Insight:

Service, fresh non-donor is expected to dominant the market in forecast period. Further, delayed pregnancy trends in women, technological advancements, advantages of fresh embryo transfer over the frozen embryo technique, increase in rate of infertility, and higher success rate of this technique are the major drivers of the fresh non-donor segment. On the other hand, egg and embryo banking is anticipated to exhibit the fastest market growth during the forecast period, owing to rise in number of egg & embryo banking and growth in demand for thaw IVF cycle.

By Region Insight:

Region wise, Asia-pacific is expected to dominant as increase in accessibility and availability of health care centers. Moreover, due to economic development this region is expected to fuel the growth of market.

The report provides extensive competitive analysis and profiles of key market players, such as Apollo Hospitals Enterprise Ltd., Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, Ova Science Inc., Progyny Inc., and Xytex Cryo International. Other players in the value chain (not included in the report) include Irvine Scientific, INVO Bioscience, Life Global Group, and IVFtech ApS.

The Key Segments of Fertility Service Market:

By Procedure

  • IVF with ICSI
  • IUI
  • IVF without ICSI
  • Surrogacy
  • Others

BY Services

  • Fresh Non-donor
  • Frozen Non-donor
  • Egg & Embryo Banking
  • Fresh Donor
  • Frozen Donor

By Region

North America

  • U.S
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • Australia
  • Rest of Asia-pacific

LAMEA

  • Latin America
  • Middle east
  • Africa


Frequently Asked Questions
The Forecast Period of the Fertility Service Market is 2021-2027.
Technological advancement in IVF with ICSI
Apollo Hospitals Enterprise Ltd., Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, Ova Science Inc., Progyny Inc., and Xytex Cryo International. Other players in the value chain (not included in the report) include Irvine Scientific, INVO Bioscience, Life Global Group, and IVFtech ApS are Active Players in Fertility Service Market.

TABLE OF CONTENTS:

CHAPTER 1 MARKET INTRODUCTION

1.1. REPORT OVERVIEW

1.2. SCOPE OF THE STUDY

1.3. PRIMARY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

2.1. C-LEVEL EXECUTIVE’S OVERVIEW AND PERSPECTIVES

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. PRINCIPAL FINDINGS

3.2.1. Key investment pockets

3.2.2. Leading winning strategies

  3.2.3 Key Player Positioning

3.3. PORTERS FIVE FORCES OF COMPETITIVE ANALYSIS

 3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.4.4. Impact Analysis

3.5. IMPACT OF COVID-19 ON THIS MARKET

CHAPTER 4 .GLOBAL FERTILTY SERVICE MARKET, BY PROCEDURE

4.1. SYNOPSIS

4.1.1. Market size and forecast

4.2. IVF with ICSI

4.2.1. Key market trends

4.2.2. Growth factors and opportunities

4.2.3. Market size and forecast

4.3. IUI

4.3.1. Key market trends

4.3.2. Growth factors and opportunities

4.3.3. Market size and forecast

  4.4 IVF without ICSI

4.4.1. Key market trends

4.4.2. Growth factors and opportunities

4.4.3. Market size and forecast

  4.5 Surrogacy

4.4.1. Key market trends

4.4.2. Growth factors and opportunities

4.4.3. Market size and forecast

CHAPTER 5 GLOBAL FERTILTY SERVICE MARKET ,BY SERVICE

  5.1 SYNOPSIS

5.1.1. Market size and forecast

  5.2 Fresh Non-donor

  5.2.1. Key market trends

5.2.2. Growth factors and opportunities

5.2.3. Market size and forecast

  5.3 Frozen Non-donor

5.3.1. Key market trends

5.3.2. Growth factors and opportunities

5.3.3. Market size and forecast

  5.4 Egg & Embryo Banking

5.4.1. Key market trends

5.4.2. Growth factors and opportunities

5.4.3. Market size and forecast

  5.5 Fresh Donor

5.5.1. Key market trends

5.5.2. Growth factors and opportunities

5.5.3. Market size and forecast

  5.6 Frozen Donor

5.6.1. Key market trends

5.6.2. Growth factors and opportunities

5.6.3. Market size and forecast

CHAPTER 6 GLOBAL FERTILY SERVICE MARKET , BY REGION

6.1 SYNOPSIS

6.2 North America

6.2.1 Key market trends

6.2.2 Competitive scenario

6.2.3 Key growth factors and opportunities

6.2.4 Market size and forecast

6.3 Europe

6.3.1 Key market trends

6.3.2 Competitive scenario

6.3.3 Key growth factors and opportunities

6.3.4 Market size and forecast

6.4 Asia Pacific

6.4.1 Key market trends

6.4.2 Competitive scenario

6.4.3 Key growth factors and opportunities

6.4.4 Market size and forecast

6.5 LAMEA

6.5.1 Key market trends

6.5.2 Key growth factors and opportunities

6.5.3 Market size and forecast

CHAPTER 7 COMPANY PROFILES

  7.1 L Apollo Hospitals Enterprise Ltd

7.1.1. Company overview

7.1.2. Company snapshot

7.1.3. Product portfolio

7.1.4. Business performance

7.1.5. Key strategic moves and developments

7.2. Care Fertility Group

7.2.1. Company overview

7.2.2. Company snapshot

  7.2.4. Product portfolio

7.2.5. Business performance

7.2.6. Key strategic moves and developments

7.3 Carolinas Fertility Institute

7.3.1. Company overview

7.3.2. Company snapshot

7.3.3. Operating business segments

7.3.4. Product portfolio

7.3.5. Business performance

7.3.6. Key strategic moves and developments

7.4. , Genea Limited

7.4.1. Company overview

7.4.2. Company snapshot

7.4.3. Operating business segments

7.4.4. Product portfolio

7.4.5. Business performance

7.4.6. Key strategic moves and developments

7.5. , The Johns Hopkins Health System Corp

7.5.1. Company overview

7.5.2. Company snapshot

7.5.3. Operating business segments

7.5.4. Product portfolio

7.5.5. Business performance

7.5.6. Key strategic moves and developments

7.6. , Medicover Group

7.6.1. Company overview

7.6.2. Company Snapshot

7.6.3. Operating business segments

7.6.4. Product portfolio

7.6.5. Business performance

7.6. Key strategic moves and developments

7.7. Monash IVF Group.

7.7.1. Company overview

7.7.2. Company snapshot

7.7.3. Operating business segments

7.7.4. Product portfolio

7.7.5. Business performance

7.7.6. Key strategic moves and developments

  7.8 Ova cience Inc.

7.8.1. Company overview

7.8.2. Company snapshot

7.8.3. Operating business segments

7.8.4. Product portfolio

7.8.5. Business performance

7.8.6. Key strategic moves and developments

7.9. , Progyny Inc.

7.9.1. Company overview

7.9.2. Company snapshot

7.9.3. Operating business segments

7.9.4. Product portfolio

7.9.5. Business performance

7.9.6. Key strategic moves and developments

7.10 Xytex Cryo International

7.10.1. Company overview

7.10.2. Company snapshot

7.10.3. Product portfolio

7.10.4. Key strategic moves and developments


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]